Literature DB >> 3313385

A plasmacytoma-specific factor binds the c-myc promoter region.

E Kakkis1, K Calame.   

Abstract

We used an electrophoretic mobility-shift assay to study proteins that bind to sequences in the 5' flanking region of the murine c-myc gene. By comparing the DNA-protein complexes formed with extracts from cells representing earlier stages of B-cell development with those from plasmacytomas, we identified a plasmacytoma-specific protein that binds to a region within the c-myc promoter. Five other regions of this promoter show extensive sequence-specific binding, but the binding is not clearly B-cell stage-specific. Methylation-interference and o-phenanthroline/copper-protection experiments identified a single plasmacytoma-specific protein binding site 290 base pairs 5' of the transcription start site P1. Homologues of a core sequence, d(AGAAAGGGAAAGGA), within the 25-base-pair binding site are found at three additional sites in the murine c-myc locus. The plasmacytoma-specific occurrence of this protein suggests that it may play a role in the transcriptional repression of the normal c-myc gene observed in plasmacytomas.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3313385      PMCID: PMC299223          DOI: 10.1073/pnas.84.20.7031

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Target sequences for cis-acting regulation within the dual promoter of the human c-myc gene.

Authors:  M Lipp; R Schilling; S Wiest; G Laux; G W Bornkamm
Journal:  Mol Cell Biol       Date:  1987-04       Impact factor: 4.272

2.  Transcriptional activation of the translocated c-myc oncogene in mouse plasmacytomas: similar RNA levels in tumor and proliferating normal cells.

Authors:  E J Keath; A Kelekar; M D Cole
Journal:  Cell       Date:  1984-06       Impact factor: 41.582

3.  Expression of c-myc changes during differentiation of mouse erythroleukaemia cells.

Authors:  H M Lachman; A I Skoultchi
Journal:  Nature       Date:  1984 Aug 16-22       Impact factor: 49.962

4.  Transcriptionally active DNA region that rearranges frequently in murine lymphoid tumors.

Authors:  J M Adams; S Gerondakis; E Webb; J Mitchell; O Bernard; S Cory
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

5.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

Review 6.  Translocations among antibody genes in human cancer.

Authors:  P Leder; J Battey; G Lenoir; C Moulding; W Murphy; H Potter; T Stewart; R Taub
Journal:  Science       Date:  1983-11-18       Impact factor: 47.728

7.  Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas.

Authors:  L W Stanton; R Watt; K B Marcu
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

8.  Intragenic pausing and anti-sense transcription within the murine c-myc locus.

Authors:  A Nepveu; K B Marcu
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

9.  Interchromosomal recombination of the cellular oncogene c-myc with the immunoglobulin heavy chain locus in murine plasmacytomas is a reciprocal exchange.

Authors:  S Cory; S Gerondakis; J M Adams
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

10.  Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours.

Authors:  O Bernard; S Cory; S Gerondakis; E Webb; J M Adams
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  15 in total

1.  An antisense promoter of the murine c-myc gene is localized within intron 2.

Authors:  D B Spicer; G E Sonenshein
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

2.  Common factor 1 is a transcriptional activator which binds in the c-myc promoter, the skeletal alpha-actin promoter, and the immunoglobulin heavy-chain enhancer.

Authors:  K J Riggs; K T Merrell; G Wilson; K Calame
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

3.  A nuclease-hypersensitive element of the human c-myc promoter interacts with a transcription initiation factor.

Authors:  E H Postel; S E Mango; S J Flint
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

Review 4.  Chemical nucleases as probes for studying DNA-protein interactions.

Authors:  A G Papavassiliou
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

5.  Transcriptional repressor ZF5 identifies a new conserved domain in zinc finger proteins.

Authors:  M Numoto; O Niwa; J Kaplan; K K Wong; K Merrell; K Kamiya; K Yanagihara; K Calame
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

6.  Germ line c-myc is not down-regulated by loss or exclusion of activating factors in myc-induced macrophage tumors.

Authors:  S E Mango; G D Schuler; M E Steele; M D Cole
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

7.  Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase.

Authors:  J Yu; C Angelin-Duclos; J Greenwood; J Liao; K Calame
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

8.  Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter.

Authors:  Han Chen; Carolyn A Gilbert; John A Hudson; Sophia C Bolick; Kenneth L Wright; Janet F Piskurich
Journal:  Mol Immunol       Date:  2006-06-12       Impact factor: 4.407

9.  LR1 regulates c-myc transcription in B-cell lymphomas.

Authors:  A Brys; N Maizels
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

10.  PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins.

Authors:  B Ren; K J Chee; T H Kim; T Maniatis
Journal:  Genes Dev       Date:  1999-01-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.